Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Lcq908
1. Lcq-908
2. 956136-95-1
3. Lcq908
4. Pradigastat Free Acid
5. Lcq-908nxa
6. Lcq908-nxa
7. Lcq-908-nxa
8. 2u23g6vnuz
9. Lcq908 - Dgat-1-inhibitor
10. 956136-95-1 (free Acid)
11. Pradigastat (usan)
12. Lcq 908
13. Pradigastat [usan]
14. 2-((1s,4s)-4-(4-(5-((6-(trifluoromethyl)pyridin-3-yl)amino)pyridin-2-yl)phenyl)cyclohexyl)acetic Acid
15. 2-[4-[4-[5-[[6-(trifluoromethyl)pyridin-3-yl]amino]pyridin-2-yl]phenyl]cyclohexyl]acetic Acid
16. 2-{4-[4-(5-{[6-(trifluoromethyl)pyridin-3-yl]amino}pyridin-2-yl)phenyl]cyclohexyl}acetic Acid
17. Pradigastat [inn]
18. Pradigastat [usan:inn]
19. Unii-2u23g6vnuz
20. Lcq 908nxa
21. Schembl180536
22. Gtpl7830
23. Schembl1289309
24. Chembl2364624
25. Schembl16104874
26. Schembl18286769
27. Dtxsid401026085
28. Bcp21089
29. Lcq908; Lcq 908; Pradigastat
30. Bdbm50502586
31. Zinc253387875
32. Cs-1222
33. Db12866
34. Sb16971
35. Ncgc00378933-01
36. Ncgc00378933-02
37. Hy-16278
38. Db-125833
39. D10664
40. A900338
41. Q27088438
42. (4-{4-[5-(6-trifluoromethyl-pyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic Acid
43. Cyclohexaneacetic Acid, 4-(4-(5-((6-(trifluoromethyl)-3-pyridinyl)amino)-2-pyridinyl)phenyl)-, Trans-
44. Lcq-908; Trans-4-[4-[5-[[6-(trifluoromethyl)-3-pyridinyl]amino]-2-pyridinyl]phenyl]cyclohexaneacetic Acid;lcq-908
45. Trans-4-[4-[5-[[6-(trifluoromethyl)-3-pyridinyl]amino]-2-pyridinyl]phenyl]cyclohexaneacetic Acid
| Molecular Weight | 455.5 g/mol |
|---|---|
| Molecular Formula | C25H24F3N3O2 |
| XLogP3 | 5.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 6 |
| Exact Mass | 455.18206150 g/mol |
| Monoisotopic Mass | 455.18206150 g/mol |
| Topological Polar Surface Area | 75.1 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 631 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of familial chylomicronaemia syndrome (type I hyperlipoproteinaemia
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
85
PharmaCompass offers a list of Pradigastat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pradigastat manufacturer or Pradigastat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pradigastat manufacturer or Pradigastat supplier.
PharmaCompass also assists you with knowing the Pradigastat API Price utilized in the formulation of products. Pradigastat API Price is not always fixed or binding as the Pradigastat Price is obtained through a variety of data sources. The Pradigastat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pradigastat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pradigastat, including repackagers and relabelers. The FDA regulates Pradigastat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pradigastat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pradigastat supplier is an individual or a company that provides Pradigastat active pharmaceutical ingredient (API) or Pradigastat finished formulations upon request. The Pradigastat suppliers may include Pradigastat API manufacturers, exporters, distributors and traders.
Pradigastat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pradigastat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pradigastat GMP manufacturer or Pradigastat GMP API supplier for your needs.
A Pradigastat CoA (Certificate of Analysis) is a formal document that attests to Pradigastat's compliance with Pradigastat specifications and serves as a tool for batch-level quality control.
Pradigastat CoA mostly includes findings from lab analyses of a specific batch. For each Pradigastat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pradigastat may be tested according to a variety of international standards, such as European Pharmacopoeia (Pradigastat EP), Pradigastat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pradigastat USP).
